Suppr超能文献

黏菌素联合替加环素对从呼吸机相关性肺炎患者中分离出的耐碳青霉烯鲍曼不动杆菌菌株的体外活性

In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.

作者信息

Cikman Aytekin, Gulhan Baris, Aydin Merve, Ceylan Mehmet Resat, Parlak Mehmet, Karakecili Faruk, Karagoz Alper

机构信息

1. Department of Medical Microbiology, Faculty of Medicine, Erzincan University, Erzincan, Turkey.

2. Viransehir State Hospital, Department of Infectious Diseases and Clinical Microbiology, Sanliurfa, Turkey.

出版信息

Int J Med Sci. 2015 Aug 14;12(9):695-700. doi: 10.7150/ijms.11988. eCollection 2015.

Abstract

OBJECTIVE

This study investigated the minimum inhibitory concentration (MIC) values and in vitro activity of colistin in combination with tigecycline against carbapenem-resistant Acinetobacter baumannii strains isolated from patients with ventilator-associated pneumonia (VAP) using the E-test method.

METHODS

A total of 40 A. baumannii strains, identified using the Phoenix Automated Microbiology System (Becton, Dickinson and Co., Franklin Lakes, NJ, USA) by conventional methods, were included in this study. Pulsed-field gel electrophoresis was performed to examine the clonal relationships between isolates. The carbapenem resistance of the strains to colistin and tigecycline was assessed using the E-test method (Liofilchem, Roseto Degli Abruzzi, Italy). The in vitro activity of colistin in combination with tigecycline was evaluated using the fractional inhibitor concentration (FIC) index.

RESULTS

While only 1 of 40 A. baumannii strains was determined to be colistin resistant, 6 were tigecycline resistant. The MIC50, MIC90, and MIC intervals of the A. baumannii strains were 0.19, 1.5, and 0.064‒4 μg/ml for colistin and 1, 8, and 0.094‒256 μg/ml for tigecycline, respectively. No synergistic effect was observed using the FIC index; 8 strains exhibited an indifferent effect and 32 exhibited an antagonist effect. Three of the six strains that were resistant to tigecycline were indifferent; the remaining three were antagonistic. The colistin-resistant strain also exhibited an antagonist effect.

CONCLUSION

In contrast to their synergistic effect against carbapenem-resistant A. baumannii isolates, colistin and tigecycline were highly antagonistic to carbapenem-resistant A. baumannii strains isolated from patients with VAP when the drugs were administered together. Therefore, alternative treatment options should be used during the treatment of VAP attributed to A. baumannii.

摘要

目的

本研究采用E-test法,调查黏菌素联合替加环素对从呼吸机相关性肺炎(VAP)患者中分离出的耐碳青霉烯类鲍曼不动杆菌菌株的最低抑菌浓度(MIC)值及体外活性。

方法

本研究共纳入40株鲍曼不动杆菌菌株,这些菌株采用常规方法通过Phoenix自动化微生物系统(美国新泽西州富兰克林湖的BD公司)进行鉴定。采用脉冲场凝胶电泳检测分离株之间的克隆关系。采用E-test法(意大利罗塞托-德利亚布鲁齐的Liofilchem公司)评估菌株对黏菌素和替加环素的碳青霉烯类耐药性。采用分数抑菌浓度(FIC)指数评估黏菌素联合替加环素的体外活性。

结果

40株鲍曼不动杆菌菌株中只有1株被确定对黏菌素耐药,6株对替加环素耐药。鲍曼不动杆菌菌株的MIC50、MIC90和MIC区间,黏菌素分别为0.19、1.5和0.064‒4 μg/ml,替加环素分别为1、8和0.094‒256 μg/ml。使用FIC指数未观察到协同作用;8株表现为无关作用,32株表现为拮抗作用。对替加环素耐药的6株菌株中有3株表现为无关作用;其余3株表现为拮抗作用。耐黏菌素菌株也表现出拮抗作用。

结论

与它们对耐碳青霉烯类鲍曼不动杆菌分离株的协同作用相反,黏菌素和替加环素联合给药时,对从VAP患者中分离出的耐碳青霉烯类鲍曼不动杆菌菌株具有高度拮抗作用。因此,在治疗由鲍曼不动杆菌引起的VAP时应采用其他治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9b/4571546/6ee65a7c5f69/ijmsv12p0695g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验